Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,742Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Biktarvy

02 5Descovy

03 5Genvoya

04 5Odefsey

05 2Revenue share - Symtuza

06 2Symtuza

PharmaCompass

01

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Odefsey

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,672

2019 Revenue in Millions : 1,655

Growth (%) : 1

blank

02

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Biktarvy

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 7,259

2019 Revenue in Millions : 4,738

Growth (%) : 53

blank

03

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Genvoya

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 3,338

2019 Revenue in Millions : 3,931

Growth (%) : -15

blank

04

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Symtuza

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 488

2019 Revenue in Millions : 379

Growth (%) : 29

blank

05

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Descovy

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,861

2019 Revenue in Millions : 1,500

Growth (%) : 24

blank

06

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Genvoya

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 2,879

2020 Revenue in Millions : 3,338

Growth (%) : -14

blank

07

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Biktarvy

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 8,624

2020 Revenue in Millions : 7,259

Growth (%) : 19

blank

08

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Odefsey

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 1,568

2020 Revenue in Millions : 1,672

Growth (%) : -6

blank

09

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Symtuza

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 531

2020 Revenue in Millions : 488

Growth (%) : 9

blank

10

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Descovy

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 1,700

2020 Revenue in Millions : 1,861

Growth (%) : -9

blank